181.

182.
Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters
by SHARON, Eilon
Nature biotechnology, 2012, Vol.30 (6), p.521-530

183.
Gene expression networks in COPD: microRNA and mRNA regulation
by Ezzie, Michael E
Thorax, 2012-02, Vol.67 (2), p.122-131

184.
Miniaturising the laboratory in emulsion droplets
by Griffiths, Andrew D
Trends in biotechnology (Regular ed.), 2006, Vol.24 (9), p.395-402

185.
Systematic exploration of essential yeast gene function with temperature-sensitive mutants
by Andrews, Brenda
Nature biotechnology, 2011-04, Vol.29 (4), p.361-367

186.
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein
by Shaner, Nathan C
Nature biotechnology, 2004-12, Vol.22 (12), p.1567-72

187.
SIMULATION OF AND TRAINING FOR CEREBRAL ANEURYSM CLIPPING WITH 3-DIMENSIONAL MODELS
by KIMURA, Toshikazu
Neurosurgery, 2009, Vol.65 (4), p.719-726

188.
Engineered ascorbate peroxidase as a genetically encoded reporter for electron microscopy
by MARTELL, Jeffrey D
Nature biotechnology, 2012, Vol.30 (11), p.1143-1148

189.
Fabrication and characterization of gold nano-wires templated on virus-like arrays of tobacco mosaic virus coat proteins
by Wn k, M
Nanotechnology, 2012-12-10, Vol.24 (2), p.025605-1-8

190.
The use of nanocrystals in biological detection
by Alivisatos, Paul
Nature biotechnology, 2004-01, Vol.22 (1), p.47-52

191.
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis
by Gustafsson, P M
Thorax, 2008-02, Vol.63 (2), p.129-134

192.
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy
by de Vries, I. Jolanda M
Nature biotechnology, 2005, Vol.23 (11), p.1407-1413

193.
Continuous blood pressure measurement by using the pulse transit time: comparison to a cuff-based method
by Gesche, Heiko
European journal of applied physiology, 2011-05-10, Vol.112 (1), p.309-315

194.
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
by Bhutta, Zulfiqar A, Prof
The Lancet (British edition), 2014, Vol.384 (9940), p.347-370

195.

196.
False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies
by Glickman, Mark E
Journal of clinical epidemiology, 2014, Vol.67 (8), p.850-857

197.
A tissue-engineered jellyfish with biomimetic propulsion
by NAWROTH, Janna C
Nature biotechnology, 2012, Vol.30 (8), p.792-797

198.
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
by Mohr, J P, Prof
The Lancet (British edition), 2014-02-15, Vol.383 (9917), p.614-621

199.
Derivation of human embryonic stem cells in defined conditions
by Thomson, James A
Nature biotechnology, 2006-03, Vol.24 (2), p.185-187

200.
Low-dose, 128-slice, dual-source CT coronary angiography: accuracy and radiation dose of the high-pitch and the step-and-shoot mode
by Alkadhi, Hatem
Heart (British Cardiac Society), 2010-06, Vol.96 (12), p.933-938
